Literature DB >> 22144192

MicroRNA in situ hybridization.

Boye Schnack Nielsen1.   

Abstract

In situ hybridization (ISH) is a technology that allows detection of specific nucleic acid sequences in tissue samples at the cellular level. For detection of individual microRNAs (miRNAs) and mRNAs, the ISH technology determines the cellular origin of expression and provides information on expression levels in different tissue compartments and cell populations. This histological expression analysis is of crucial importance for elucidating roles particularly of miRNAs in molecular and biological processes. mRNA expression analyses can partly be replaced by immunohistochemical detection of the protein encoded by the mRNA. Combined with the short sequences of the miRNAs (18-22 bp), this leaves miRNA ISH as an indispensable yet challenging technology in terms of detection and specificity analysis. In this chapter, a simple miRNA ISH protocol using chromogenic detection is presented. I touch upon critical steps in the ISH protocol, different applications on ISH technology platforms, advantageous use of locked nucleic acids (LNA™) in miRNA detection probes, qualification of clinical paraffin samples, and specificity analyses and quantification of the ISH signal.

Mesh:

Substances:

Year:  2012        PMID: 22144192     DOI: 10.1007/978-1-61779-427-8_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  miR-126 regulates glycogen trophoblast proliferation and DNA methylation in the murine placenta.

Authors:  Abhijeet Sharma; Lauretta A Lacko; Lissenya B Argueta; Michael D Glendinning; Heidi Stuhlmann
Journal:  Dev Biol       Date:  2019-02-14       Impact factor: 3.582

Review 2.  MicroRNAs and Transplantation.

Authors:  Zahraa Khan; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  Clin Lab Med       Date:  2018-12-22       Impact factor: 1.935

Review 3.  Detection of miRNAs with a nanopore single-molecule counter.

Authors:  Li-Qun Gu; Meni Wanunu; Michael X Wang; Larry McReynolds; Yong Wang
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

Review 4.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

Review 5.  microRNA-based diagnostic and therapeutic applications in cancer medicine.

Authors:  Lorenzo F Sempere; Asfar S Azmi; Anna Moore
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-05-17       Impact factor: 9.957

6.  The prognostic importance of miR-21 in stage II colon cancer: a population-based study.

Authors:  S Kjaer-Frifeldt; T F Hansen; B S Nielsen; S Joergensen; J Lindebjerg; F B Soerensen; R dePont Christensen; A Jakobsen
Journal:  Br J Cancer       Date:  2012-09-25       Impact factor: 7.640

7.  Identification of ovarian cancer metastatic miRNAs.

Authors:  Souriya Vang; Hsin-Ta Wu; Andrew Fischer; Daniel H Miller; Shannon MacLaughlan; Elijah Douglass; Lauren Comisar; Margaret Steinhoff; Colin Collins; Peter J S Smith; Laurent Brard; Alexander S Brodsky
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

8.  Single cell microRNA analysis using microfluidic flow cytometry.

Authors:  Meiye Wu; Matthew Piccini; Chung-Yan Koh; Kit S Lam; Anup K Singh
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

9.  Genome-wide identification of miRNAs responsive to drought in peach (Prunus persica) by high-throughput deep sequencing.

Authors:  Vahap Eldem; Ufuk Çelikkol Akçay; Esma Ozhuner; Yakup Bakır; Serkan Uranbey; Turgay Unver
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

Review 10.  Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?

Authors:  Lorenzo F Sempere
Journal:  Expert Rev Mol Diagn       Date:  2014-08-04       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.